Silverfleet Capital related stories
All articles and analysis
European People Briefs, January 2013SVB creates new U.K. role; Octopus adds to its ventures team
Silverfleet Capital Promotes ThreeEuropean private equity firm Silverfleet Capital has promoted three of its investment team. Mark Piasecki, who is based in London, has been promoted to principal. Robert Knight, also based in London, and Cyril Bourdarot who is based in Paris, have become investment executives.
- European LP Briefs, December 2011
CDC announces two investments; ILPA sets minimum disclosure level
- Silverfleet Takes on LDC Investment
London-based private equity firm Silverfleet Capital has agreed a majority investment with Aesica Pharmaceuticals replacing that of LDC. Members of Aesica’s executive team will reinvest a significant amount of money for a large minority stake. Debt is being provided by Lloyds, HSBC and Yorkshire Bank.Headquartered near Newcastle, UK, Aesica has the expertise to both develop and manufacture primary (API) and secondary stage (finished product dosage forms) pharmaceuticals.
- European People Briefs, July 2011
Alexandre Lefebvre joins Silverfleet; Maven Capital Partners hires staff for third office in Scotland
- GTCR Completes Sterigenics Buy
Buyout shop GTCR has completed its acquisition of Sterigenics International Inc., a provider of contract sterilization and ionization services for medical devices, food products and other applications. The firm bought Oak Brook, Illinois-based Sterigenics from Silverfleet Capital and PPM America Capital Partners. Terms were not released. Jefferies & Company, Bank of America Merrill Lynch and UBS advised GTCR on the transaction.
- Cinven dilutes stake in Jost with debt-for-equity swap
Cinven, a private equity firm based in London, is close to selling its stake in Jost, a German truck and trailer parts maker, to creditors. According to Reuters, an earnings slump prompted Jost’s management, its private equity backers, and holders of just under 400 million euros ($554 million) of loans to enter into a debt-for-equity swap. The arrangement could drop Cinven’s stake in Jost from 73 percent to 65 percent, while management, which holds the other 27 percent, would lose 7 percent.
- Silverfleet Plans To Sell Sterigenics
(Reuters) - Private equity firm Silverfleet Capital is seeking to sell Sterigenics, the Chicago-based firm whose gamma-ray sterilisation technology is used by medical device makers, sources familiar with the situation said on Thursday. Silverfleet is hoping the business, which it bought in 2004, will fetch about $800 million and expects it will attract interest from private equity firms and trade bidders, the sources said. Silverfleet declined comment. Sterigenics's listed competitors include Steris Corp (STE.N) and Canada's MDS Nordion (MDS.TO).